As an assistant professor at Harvard medical school, Dr. Rebecca Zash is an infectious diseases physician and performs research focused on the impact of HIV and antiretroviral medications on pregnancy, and holds a research associate position with BHP. Dr. Zash went to medical school at the University of North Carolina, and completed internal medicine residency and infectious disease fellowship at Beth Israel Deaconess Medical Center in Boston, USA. She has been working with BHP since 2013 and currently serves as PI for one study to understand why HIV-infected women on ART have an increased risk of adverse birth outcomes and one study to evaluate cardiometabolic adverse effects of ART in post-partum women and their infants. She also helps to lead a large birth outcomes surveillance study, Tsepamo, which examines the comparative safety of antiretroviral treatments in pregnancy.